{
  "abstract": "Immune checkpoint inhibitors (ICIs) may cause rare life‐threatening ICI‐associated diabetes mellitus. We report a 60‐year‐old Chinese male with pre‐existing type 2 diabetes who developed toripalimab‐induced diabetic ketoacidosis after 3 treatment cycles. He also had toripalimab‐related hyperthyroidism. Clinicians should closely monitor plasma glucose during and after ICI therapy.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Internal Medicine The Third People's Hospital of Baiyun District Guangzhou Guangdong China",
    "Department of Clinical Laboratory The Third People's Hospital of Baiyun District Guangzhou Guangdong China"
  ],
  "article_type": "case study",
  "arxiv": null,
  "author_total": 2,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Lingfen Zeng",
      "orcid": "0009-0004-1693-5799"
    },
    {
      "affs": [
        1
      ],
      "name": "Jieming Sun"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/4vdhpsc7cnph9.bib",
  "cited_by": 0,
  "doi": "10.1002/ccr3.73834",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13731963/",
  "id": "4vdhpsc7cnph9",
  "issns": [
    "2050-0904"
  ],
  "landing_url": "https://doi.org/10.1002/ccr3.73834",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Case Report"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225245896",
  "pdf_url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ccr3.73834",
  "pmcid": "PMC13731963",
  "pmid": "42985145",
  "published": "2026-11-03",
  "publisher": "Wiley",
  "ris": "https://research.draconitic.com/paper/4vdhpsc7cnph9.ris",
  "sources": [
    {
      "first_seen": "2026-11-08T12:22:02Z",
      "native_id": "PMC13731963",
      "source": "pmc",
      "url": "https://doi.org/10.1002/ccr3.73834"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "Immune Checkpoint Inhibitor‐Induced Diabetic Ketoacidosis in a Patient With Pre‐Existing Type 2 Diabetes: A Case Report",
  "title_text": "Immune Checkpoint Inhibitor‐Induced Diabetic Ketoacidosis in a Patient With Pre‐Existing Type 2 Diabetes: A Case Report",
  "type": "peer-reviewed",
  "updated_at": "2026-11-08T12:22:02Z",
  "url": "https://research.draconitic.com/paper/4vdhpsc7cnph9",
  "venue": "Clinical Case Reports",
  "versions": []
}